Quantitative sequencing of SARS-CoV-2 viral RNA modifications and identification of host modification enzymes critical to viral RNA replication A new coronavirus disease (known as COVID-19) has swept 200 countries and was declared a pandemic. The causative agent is named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There is no effective vaccine currently available for SARS-CoV-2. FDA has approved two anti-malaria drugs, chloroquine and hydroxychloroquine, for emergency use for treatment of COVID-19. In addition, remdesivir, a nucleotide analog used for treatment of Ebola virus disease, is now in clinical trials and clinical use for COVID-19 treatment. Understanding properties of SARS-CoV-2 and revealing cellular components essential to its infection are critical to development of effective therapies and vaccines in the near future. SARS-CoV-2 is an RNA virus. Its viral RNAs have been shown to be chemically modified. Previous studies from us and others have revealed crucial roles of viral RNA modifications in viral replication and immune evasion. Our most recent data indicate that an RNA m5C methyltransferase NSUN2 plays a vital role in human coronavirus replication inside host cells. In this administrative supplement application we propose to apply quantitative sequencing methods developed by our CEGS to map N6-methyladenosine (m6A), 5-methylcytosine (m5C), pseudouridine (?), 2?-O-methylation (Nm), N7-methylguanosine (m7G) and N1-methyladenosine (m1A) in SARS-CoV-2 RNA. We will also assign modification enzymes and test their effects on viral infection using established infection models of SARS-CoV-2. We will specifically examined NSUN2 and its effect on viral RNA m5C methylation, and test known inhibitors for inhibition of viral infection. We will also examine potential roles of m6A and related modifications in protecting viral RNA from host innate immune responses.

Public Health Relevance

COVID-19 is a new coronavirus disease caused by an RNA virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We have recently found that chemical modifications on human coronavirus can play crucial roles in viral replication and immune evasion inside host cells. We propose to quantitatively map all main modifications on SARS-CoV-2 RNA, identify key enzymes that install these modifications and test known inhibitors for inhibiting viral replication in order to facilitate development of therapies and vaccines.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Research Project with Complex Structure (RM1)
Project #
3RM1HG008935-05S1
Application #
10163382
Study Section
National Human Genome Research Institute Initial Review Group (GNOM)
Program Officer
Smith, Michael
Project Start
2016-09-27
Project End
2021-06-30
Budget Start
2020-09-12
Budget End
2021-06-30
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Chicago
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Frye, Michaela; Harada, Bryan T; Behm, Mikaela et al. (2018) RNA modifications modulate gene expression during development. Science 361:1346-1349
Wei, Jiangbo; Liu, Fange; Lu, Zhike et al. (2018) Differential m6A, m6Am, and m1A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm. Mol Cell 71:973-985.e5
Huang, Huilin; Weng, Hengyou; Sun, Wenju et al. (2018) Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol 20:285-295
Weng, Hengyou; Huang, Huilin; Wu, Huizhe et al. (2018) METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. Cell Stem Cell 22:191-205.e9
Hsu, Phillip J; Fei, Qili; Dai, Qing et al. (2018) Single base resolution mapping of 2'-O-methylation sites in human mRNA and in 3' terminal ends of small RNAs. Methods :
Yao, Bing; Li, Yujing; Wang, Zhiqin et al. (2018) Active N6-Methyladenine Demethylation by DMAD Regulates Gene Expression by Coordinating with Polycomb Protein in Neurons. Mol Cell 71:848-857.e6
Li, Miaomiao; Zhao, Xu; Wang, Wei et al. (2018) Ythdf2-mediated m6A mRNA clearance modulates neural development in mice. Genome Biol 19:69
Su, Rui; Dong, Lei; Li, Chenying et al. (2018) R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling. Cell 172:90-105.e23
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Shi, Hailing; Zhang, Xuliang; Weng, Yi-Lan et al. (2018) m6A facilitates hippocampus-dependent learning and memory through YTHDF1. Nature 563:249-253

Showing the most recent 10 out of 30 publications